Shanghai Pharmaceuticals Invests to Set Up E-commerce Company; "Three Platforms, Three Layers of Networks" China's first e-commerce company of prescription drugs integrating both online solutions and offline retail resources take the initiative HONG KONG, Mar 10, 2015 - (ACN Newswire) - The integrated pharmaceutical company in the PRC that has leading positions in both pharmaceutical products and distribution markets - Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 2607.HK) is pleased to announce that Shanghai Pharmaceuticals Greater Health Online Company is set up by Shanghai Pharmaceuticals and the e-commerce management team through co-investment in this drug e-commerce JV. The company is positioned to provide patients with the O2O sales of the prescription drugs, health management services and at the same time as e-commerce trader. In total, Shanghai Pharmaceuticals invested RMB 70 million while the e-commerce management team invested RMB 30 million to set up this new company. At the key point in the upcoming launch of the online sales of the prescription drugs, Shanghai Pharmaceuticals using O2O channel for the prescription drugs as the entry point of the "Cloud Commerce" in pharmaceutical can be regarded as its strategically crucial step. The core of the Shanghai Pharmaceuticals e-commerce model is to create the three platforms of "Electronic Prescription", "Medicine Data" and "Patients' Data" providing online solutions; integrating the abundant retail resources of Shanghai Pharmaceuticals as well as working up the layout of the three retail networks. In doing so, they provide patients with a professional, safe and convenient channel for the purchase of prescription drugs and the provision of long-term comprehensive health management services so as to achieve the integration of trade and services, sheer linkage between hospitals and prescription, entire interaction of doctors and patients as well as merging of the online and offline commerce. At present, the mainstream of the pharmaceutical e-commerce models in China is divided into two categories - trade and services. Among them, the "category of trade model" is further divided into the type of e-commerce platform and the type of e-commerce entity which relies on the offline commerce. According to the analysis of the industry, it is required to optimize the e-commerce and the retail channels on the basis of the current e-commerce in order to build up a true ecological chain system of pharmaceuticals, which opens up the end-to-end process flow scheme of drugs. Shanghai Pharmaceuticals official said the company will establish three online information platforms for the realization of the comprehensive process of services including the diversion of prescription, purchase of drugs, health management and making follow-up consultation appointment, etc. "Electronic Prescription" platform connects to HIS system or builds the prescription system of "self-paid drugs" itself. "Medicine Data" platform connects to and manages the retail networks of the medicine inventory, distribution and other information of Shanghai Pharmaceuticals and its cooperation partners so as to ensure fast and accurate drug logistics distribution. "Patients' Data" platform is for the long-term track record of the patients' treatment, medication, diagnostic and other health data. For offline, it will strive to establish three retail networks, including the designated pharmacies (DTP) owned by Shanghai Pharmaceuticals, outsourced hospital pharmacies or cooperative pharmacies with hospital, and many types of retail pharmacies in the community. Compared to the existing e-commerce mode of prescription, Shanghai Pharmaceuticals possesses the following advantages of the offline commerce. First, they own a relatively large offline distribution network. Second, through the implementation of outsourcing the supply chain service of the hospital, they have gained wealth of experience in hospital construction related to prescription and connection to HIS system, etc. Third, its direct to pharmacy (DTP) business is an industry leading player in the realm of expensive self-paid drugs. The new e-commerce company of Shanghai Pharmaceuticals will also take the internet-related models as references for providing patients with multiple levels of health services, such as patient education, charity donation of medicine, chronic disease management. It aims at further enhancing the cohesion of patients and their experiences. At the same time, the company will also provide the hospitals and doctors with the health management services according to those data and disease management. In addition, particularly noteworthy is that Shanghai Pharmaceuticals has implemented management shareholding and mixed ownership arrangements at the beginning of the set up. Judging from the announcement, the new company will establish the management team by Mr. JI Jun who is the current General Manager of the Shanghai Zhongxie Pharmaceutical Ltd. The team has a wealth of business and marketing experience. Together with the wealth of pharmaceutical resources of its parent company, it is further strengthened by the execution of a pragmatic business model and the incentives scheme of the management. This also leaves ample room for its future growth of the business performance and a more open shareholding structure as well as the cooperation mode.
No comments:
Post a Comment